RNAZ

TransCode Therapeutics, Inc. is a clinical-stage oncology company focused on developing RNA therapeutics for cancer treatment. The company utilizes its proprietary TTX nanoparticle platform to deliver therapeutic RNA to tumor cells, targeting metastatic disease. TransCode is advancing RNA-based therapies designed to address mechanisms that drive cancer progression and metastasis.